相关实验视频
Updated: May 22, 2025
16:31
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
24.7K
在接受CRRT的重症患者中,合体与晶体原始化对早期血液动力学的影响:随机对照试验的协议
Renli Mao1,2, Zhifeng Zhou1, Yingying Yang1
1Department of Nephrology, West China Hospital of Sichuan University, Chengdu, China.
BMJ open
|March 13, 2025
概括
这项研究比较了连续脏替代疗法 (CRRT) 的合体与晶体原始化,以减少低血压. 结果将决定合物原始化是否改善了重症患者的结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 关键护理医学 关键护理医学
- 临床试验 临床试验
背景情况:
- 低血压是连续置换疗法 (CRRT) 的常见和危险并发症,影响高达43%的患者.
- 目前在CRRT期间预防早期低血压的策略,如正常的盐水初始化,已经被证明是不够的.
- 结合体液正在被探索为管道初始化以减轻低血压的晶体液的替代品,但证据有限.
研究的目的:
- 为了比较合体原始化与晶体原始化在降低CRRT期间早期低血压的疗效.
- 评估化物化对所有原因死亡率,重症监护室 (ICU) 住院时间和透析依赖性的影响.
主要方法:
- 一个单中心,前性,随机对照试验,涉及216名参与者.
- 参与者将被随机分配,接受顺凝 (合物) 或正常盐水 (晶体) 管道初始化.
- 主要结果是CRRT期间早期低血压的发生率;结果评估人员和数据分析人员将被蒙蔽.
主要成果:
- 这项研究旨在确定合体原始化是否优于晶体原始化在预防早期低血压方面.
- 二次结果分析将评估两组之间所有原因死亡率,ICU住院时间和透析依赖度的差异.
- 数据将基于随机分组进行分析,重点是初级结果数据.
结论:
- 这项试验旨在提供关键证据,证明合物原始剂在控制CRRT诱导的低血压时的有效性.
- 这些发现可能会导致改善患者管理策略,潜在地减少不良事件并改善重症患者的治疗结果.
- 该研究将为正在进行的关于CRRT最佳原始化解决方案的讨论提供有价值的数据.
相关概念视频
01:22Heart Failure Drugs: Diuretics
313
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
313
01:17Factors Affecting Renal Clearance: Renal Impairment
46
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
46
01:11Renal Failure: Dose Adjustments
52
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
52
01:27Dialysis
246
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
246
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
356
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
356
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
78
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
78